Oxidative stress and iron imbalance in Alzheimer disease: How rust became the fuss!

Journal of Alzheimer's Disease

Volumn 9, Issue SUPPL. 3, 2006, Pages 305-308

  Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CHELATING AGENT; DEFEROXAMINE; IRON; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; BRAIN; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; IRON METABOLISM; NEUROLOGIC DISEASE; NEUROPATHOLOGY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 84880190029     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2006-9s334     Document Type: Review

References (37)

1. G. Perry, A.K. Raina, M.L. Cohen and M.A. Smith, When hypotheses dominate, The Scientist 18 (2004), 6.
2. R.N. Martins, C.G. Harper, G.B. Stokes and C.L. Masters, Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress, J Neurochem 46 (2004), 1042-1045.
3. K. Jellinger, W. Paulus, I. Grundke-Iqbal, P. Riederer and M.B. Youdim, Brain iron and ferritin in Parkinson's and Alzheimer's diseases, J Neural Transm Park Dis Dement Sect 2 (2004), 327-340.
4. C.D. Smith, J.M. Carney, P.E. Starke-Reed, C.N. Oliver, E.R. Stadtman, R.A. Floyd and W.R. Markesbery, Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease, Proc Natl Acad Sci USA 88 (2004), 10540-10543.
5. M.A. Smith, S. Taneda, P.L. Richey, S. Miyata, S.D. Yan, D. Stern, L.M. Sayre, V.M. Monnier and G. Perry, Advanced Maillard reaction end products are associated with Alzheimer disease pathology, Proc Natl Acad Sci USA 91 (2004), 5710-5714.
6. M.P. Mattson, J.W. Carney and D.A. Butterfield, A tombstone in Alzheimer's? Nature 373 (2004), 481.
7. V.M. Monnier and A. Cerami, Nonenzymatic browning in vivo: possible process for aging of long-lived proteins, Science 211 (2004), 491-493.
8. R.E. Tanzi, J.F. Gusella, P.C. Watkins, G.A. Bruns, P. St George-Hyslop, M.L. Van Keuren, D. Patterson, S. Pagan, D.M. Kurnit and R.L. Neve, Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus, Science 235 (2004), 880-884.
9. B.A. Yankner, L.R. Dawes, S. Fisher, L. Villa-Komaroff, M.L. Oster-Granite and R.L. Neve, Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease, Science 245 (2004), 417-420.
10. C. Behl, J. Davis, G.M. Cole and D. Schubert, Vitamin E protects nerve cells from amyloid beta protein toxicity, Biochem Biophys Res Commun 186 (2004), 944-950.
11. P.F. Good, D.P. Perl, L.M. Bierer and J. Schmeidler, Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study, Ann Neurol 31 (2004), 286-292.
12. J.R. Connor, S.L. Menzies, S.M. St Martin and E.J. Mufson, A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains, J Neurosci Res 31 (2004), 75-83.
13. J.R. Connor, B.S. Snyder, J.L. Beard, R.E. Fine and E.J. Mufson, Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease, J Neurosci Res 31 (2004), 327-335.
14. E. Sofic, W. Paulus, K. Jellinger, P. Riederer and M.B. Youdim, Selective increase of iron in substantia nigra zona compacta of parkinsonian brains, J Neurochem 56 (2004), 978-982.
15. B. Halliwell, Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? Acta Neurol Scand Suppl 126 (2004), 23-33.
16. M.A. Smith, P.L. Harris, L.M. Sayre and G. Perry, Iron accumulation in Alzheimer disease is a source of redox-generated free radicals, Proc Natl Acad Sci USA 94 (2004), 9866-9868.
17. L.M. Sayre, G. Perry and M.A. Smith, In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders, Methods Enzymol 309 (2004), 133-152.
18. J. Savory, C. Exley, W.F. Forbes, Y. Huang, J.G. Joshi, T. Kruck, D.R. McLachlan and I. Wakayama, Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered? J Toxicol Environ Health 48 (2004), 615-635.
19. X. Huang, M.P. Cuajungco, C.S. Atwood, M.A. Hartshorn, J.D. Tyndall, G.R. Hanson, K.C. Stokes, M. Leopold, G. Multhaup, L.E. Goldstein, R.C. Scarpa, A.J. Saunders, J. Lim, R.D. Moir, C. Glabe, E.F. Bowden, C.L. Masters, D.P. Fairlie, R.E. Tanzi and A.I. Bush, Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction, J Biol Chem 274 (2004), 37111-37116.
20. D. Schubert and M. Chevion, The role of iron in beta amyloid toxicity, Biochem Biophys Res Commun 216 (2004), 702-707.
21. C.A. Rottkamp, A.K. Raina, X. Zhu, E. Gaier, A.I. Bush, C.S. Atwood, M. Chevion, G. Perry and M.A. Smith, Redox-active iron mediates amyloid-beta toxicity, Free Radic Biol Med 30 (2004), 447-450.
22. K. Honda, M.A. Smith, X. Zhu, D. Baus, W.C. Merrick, A.M. Tartakoff, T. Hattier, P.L. Harris, S.L. Siedlak, H. Fujioka, Q. Liu, P.I. Moreira, F.P. Miller, A. Nunomura, S. Shimohama and G. Perry, Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron, J Biol Chem (2004).
23. A. Nunomura, G. Perry, M.A. Pappolla, R. Wade, K. Hirai, S. Chiba and M.A. Smith, RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease, J Neurosci 19 (2004), 1959-1964.
24. A. Nunomura, G. Perry, M.A. Pappolla, R.P. Friedland, K. Hirai, S. Chiba and M.A. Smith, Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome, J Neuropathol Exp Neurol 59 (2004), 1011-1017.
25. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P.K. Jones, H. Ghanbari, T. Wataya, S. Shimohama, S. Chiba, C.S. Atwood, R.B. Petersen and M.A. Smith, Oxidative damage is the earliest event in Alzheimer disease, J Neuropathol Exp Neurol 60 (2004), 759-767.
26. M.A. Smith, G. Casadesus, J.A. Joseph and G. Perry, Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain, Free Radic Biol Med 33 (2004), 1194-1199.
27. M. Perez, R. Cuadros, M.A. Smith, G. Perry and J. Avila, Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal, FEBS Lett 486 (2004), 270-274.
28. A. Gomez-Ramos, J. Diaz-Nido, M.A. Smith, G. Perry and J. Avila, Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells, J Neurosci Res 71 (2004), 863-870.
29. S.D. Yan, X. Chen, A.M. Schmidt, J. Brett, G. Godman, Y.S. Zou, C.W. Scott, C. Caputo, T. Frappier and M.A. Smith, Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress, Proc Natl Acad Sci USA 91 (2004), 7787-7791.
30. D. Pratico, C.M. Clark, F. Liun, J. Rokach, V.Y. Lee and J.Q. Trojanowski, Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease, Arch Neurol 59 (2004), 972-976.
31. F. Li, N.Y. Calingasan, F. Yu, W.M. Mauck, M. Toidze, C.G. Almeida, R.H. Takahashi, G.A. Carlson, M. Flint Beal, M.T. Lin and G.K. Gouras, Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice, J Neurochem 89 (2004), 1308-1312.
32. G. Perry, A. Nunomura, A.K. Raina and M.A. Smith, Amyloid-beta junkies, Lancet 355 (2004), 757.
33. H.G. Lee, G. Casadesus, X. Zhu, J.A. Joseph, G. Perry and M.A. Smith, Perspectives on the amyloid-beta cascade hypothesis, J Alzheimers Dis 6 (2004), 137-145.
34. H.G. Lee, G. Casadesus, X. Zhu, A. Takeda, G. Perry and M.A. Smith, Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease, Ann N Y Acad Sci 1019 (2004), 1-4.
35. J. Joseph, B. Shukitt-Hale, N.A. Denisova, A. Martin, G. Perry and M.A. Smith, Copernicus revisited: amyloid beta in Alzheimer's disease, Neurobiol Aging 22 (2004), 131-146.
36. C.A. Rottkamp, C.S. Atwood, J.A. Joseph, A. Nunomura, G. Perry and M.A. Smith, The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease, Peptides 23 (2004), 1333-1341.
37. H.G. Lee, G. Perry, P.I. Moreira, M.R. Garrett, Q. Liu, X. Zhu, A. Takeda, A. Nunomura and M.A. Smith, Tau phosphorylation in Alzheimer's disease: pathogen or protector? Trends Mol Med 11 (2004), 164-169.